OCRF-funded research project

EFFECT OF ASCITIC FLUIDS ON THE INHIBITION OF EGFR/HER2

Institution: University of Otago

Lead Researcher: Dr Kenny Chitcholtan

Funding Awarded: $86,667

Year/s: 2016-2017


Project Description:

Ascites are a build up of fluid that occurs in the abdomen during the occurrence of a variety of diseases including some ovarian cancers. The impact that ascites can have on floating ovarian cancer cells, a source of cell that can be a catalyst for secondary tumours to grow and metastasis, is not well understood. The team’s preliminary data demonstrated, in in vitro studies, that ascitic fluid reduced the effect of inhibitors including EGFR/HER-2 which are molecules present in cancer patients. This project sought to expand on these findings with the hope of understanding the effect of ascitic fluids on the responsiveness of ovarian cancer to chemotherapy. The team hoped to understand why ascites fluid helped cancer cells survive and how they could be targeted to prevent metastasis.

Expected/Achieved Outcomes:

Knowledge Building: The team tested a variety of drugs to determine which would targets the effects of EGFR/HER-2 with published findings resulting from the work.

OCRF funding for this project has ended and the team continue to validate alternative targets and treatment options.

Further Details and Publications:

Medical Journal

Read more about published findings from this project.

panel Image
Get the latest news, stories & updates.
The Ovarian Cancer Research Foundation acknowledges the Traditional Custodians of the lands upon which we work, strive, and learn, the Wurrundjiri Woi wurrung and Bunorung Boon wurrung peoples of the Kulin Nation. We pay our respects to Elders past and present, and extend this respect to all Aboriginal and Torres Strait Islander peoples in Australia and beyond.